Green Growth Brands to Hold Third Quarter Fiscal 2019 Earnings Conference Call on May 30, 2019 Cannabis Investing News
Agile Therapeutics Announces FDA Acceptance of the NDA Resubmission of Twirla® Pharmaceutical Investing
BrainsWay Announces its Multicenter Smoking Cessation Study Has Reached Target Enrollment Medical Device Investing
New York City Ichan School of Medicine at Mount Sinai and Renowned Global Researcher Dr. Hurd, Select MediPharm Labs to Support 500 Patient Major Clinical Study and “CBD International Consortium” to Develop Treatment of Opioid Addiction Cannabis Investing News
MediPharm Labs Australia Awarded Cannabis Manufacturing Licence From Office of Drug Control – Establishes Asia-Pacific Foothold Cannabis Investing News
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia